Granulocyte-Colony Stimulating Factor (G-CSF)-Primed, Delayed Marrow Harvests as a Source of Hematopoietic Stem and Progenitor Cells for Allogeneic Transplantation

References

• Korbling M, Champlin R. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells 1996; 14: 185–95
   PubMed Web of Science ®Google Scholar
• Janssen WE. Peripheral blood and bone marrow hematopoietic stem cells: are they the same?. Semin Oncol 1993; 20: 19–27
   PubMed Web of Science ®Google Scholar
• Fielding AK, Watts MJ, Goldstone AH. Peripheral blood progenitor cells versus bone marrow. J Hematother 1994; 3: 299–304
   PubMedGoogle Scholar
• Weisdorf DJ, Verfaille CM, Miller WJ, et al. Autolo-gous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial. Am J Hematol 1997; 54: 202–8
   PubMed Web of Science ®Google Scholar
• Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood- and marrowderived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 1995; 4: 139–40
   PubMedGoogle Scholar
• Damiani D, Fanin R, Silvestri F, et al. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997; 90: 36–42
   PubMed Web of Science ®Google Scholar
• Weisdorf D, Miller J, Verfaille C, et al. Cytok-ine-primed bone marrow stem cells vs peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs G-CSF. Biol Blood Marrow Transplant 1994; 3(4)217–23
   Google Scholar
• Dicke KA, Hood DL, Ameson M, et al. Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting. Exp Hemarol 1997; 25(1)34–8
   Google Scholar
• Lowenthal RM, Sullivan SA, Parker N, Marsden KA. G-CSF-primed bone marrow cells for autologous transplantation. Lancet 1996; 347(9008)1125
   PubMed Web of Science ®Google Scholar
• Hansen PB, Johnsen HE, Ralfkiaer E, et al. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF, or rhIL-3 before marrow harvest expands myelpoiesis but does not improve engraftment capability. Bone Marrow Transplant 1995; 16(3)373–379
   PubMed Web of Science ®Google Scholar
• lsola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997; 20(2)1033–37
   PubMedGoogle Scholar
• Mavroudis DA, Read EJ, Molldrem J, et al. T-cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia. Bone Marrow Transplant 1998; 21(5)431–440
   PubMed Web of Science ®Google Scholar
• Emerson SG. The potential for clinical ex vivo hematopoiesis. Ann NY Acad Sci 1995; 70: 99–104
   Web of Science ®Google Scholar
• Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: lmplications for gene therapy. Nat Med 1996; 2(12)1329–37
   PubMed Web of Science ®Google Scholar
• Bungart B, Loeffler M, Goris H, et al. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 1990; 76(2)174–79
   PubMed Web of Science ®Google Scholar
• de Haan G, Dontje B, Engel C, et al. The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood 1995; 86(8)298–692
   Google Scholar
• Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996; 88(1)89–97
   PubMed Web of Science ®Google Scholar
• Dunbar CE, Seidel NE, Doren S, et al. Improved ret-roviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1996; 93(21)11871–6
   PubMed Web of Science ®Google Scholar
• Beelen DW, Ottinger HD, Elmaagacli A, et al. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997; 90(12)4725–35
   PubMed Web of Science ®Google Scholar
• Anderlini P, Przepiorka D, Champlin R, Korbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88(8)2819–25
   PubMed Web of Science ®Google Scholar
• Sosman JA, Stiff PJ, Bayer RA, et al. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granu-locyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplant 1995; 16(5)655–61
   PubMed Web of Science ®Google Scholar
• Vliagoftis H, Worobec AS, Metcalfe DD. The pro-tooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol 1997; 100(4)4354
   Google Scholar
• Brashem-Stein C, Flowers DA, Bernstein ID. Regulation of colony forming cell generation by flt-3 ligand. Br J Haematol 1996; 94(1)17–22
   PubMed Web of Science ®Google Scholar
• Storek J, Gooley T, Siadek M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90(12)4705–09
   PubMed Web of Science ®Google Scholar